The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Distributes Ayushman cards to several beneficiaries
OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
The collaboration brings a seamless digital experience to more formulators worldwide
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
PhytoSquene now available for clinical and commercial use
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Subscribe To Our Newsletter & Stay Updated
